Menu

• Ask a Health Expert about TUMOUR LYSIS SYNDROME
• Post Your Side Effect related to TUMOUR LYSIS SYNDROME
• TUMOUR LYSIS SYNDROME and FDA Warnings
• TUMOUR LYSIS SYNDROME in Patients Wiki
• Report TUMOUR LYSIS SYNDROME in Drug Side Effect Survey

TUMOUR LYSIS SYNDROME side effect

What is TUMOUR LYSIS SYNDROME ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Cisplatin Side Effects Report #5648260-3
Health Professional from KOREA, REPUBLIC OF reported CISPLATIN problem on Feb 28, 2008. Male patient, 38 years of age, was diagnosed with metastatic gastric cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . CISPLATIN dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient recovered.

Cisplatin Side Effects Report #5661349-8
CISPLATIN problem was reported by a Consumer or non-health professional from on Feb 28, 2008. Male patient was diagnosed with metastatic gastric cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . CISPLATIN dosage: 60 MG/M2 ON DAY 1. During the same period patient was treated with CAPECITABINE. Patient recovered.

Erbitux Side Effects Report #5671054-X
Physician from UNITED STATES reported ERBITUX problem on Mar 17, 2008. Male patient, weighting 148.0 lb, was diagnosed with colon cancer metastatic and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . ERBITUX dosage: 400MG/M2 ONCE IV. Patient died on 01/28/2008.

Erlotinib Side Effects Report #5692110-6
ERLOTINIB problem was reported by a Physician from JAPAN on Feb 14, 2008. Female patient, 56 years of age, was diagnosed with lung neoplasm malignant and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . ERLOTINIB dosage: (150 MG,QD), ORAL. During the same period patient was treated with ALDACTONE, CYTOTEC, VOLTAREN, HOCHU, LASIX, MEXITIL, METHYCOBAL, NOVAMIN. Patient recovered.


Cisplatin Side Effects Report #5642581-6
Health Professional from KOREA, REPUBLIC OF reported CISPLATIN problem on Feb 25, 2008. Male patient, 38 years of age, was diagnosed with metastatic gastric cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . CISPLATIN dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient recovered.

Velcade Side Effects Report #5584698-0
VELCADE problem was reported by a Physician from JAPAN on Dec 20, 2007. Male patient, 47 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . VELCADE dosage: 1.70 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, BAKTAR, LANSOPRAZOLE, GASMOTIN, PLATELETS, RED BLOOD CELLS. Patient died on 08/14/2007.

Velcade Side Effects Report #5536812-0
Physician from JAPAN reported VELCADE problem on Nov 27, 2007. Male patient, 58 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . VELCADE dosage: 2.00 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5552416-8
VELCADE problem was reported by a Physician from JAPAN on Nov 29, 2007. Male patient, 58 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . VELCADE dosage: 2.00 MG, INTRAVENOUS. Patient recovered.

Velcade Side Effects Report #5569986-6
Physician from JAPAN reported VELCADE problem on Dec 07, 2007. Male patient, 58 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . VELCADE dosage: 2.00 MG, INTRAVENOUS. Patient recovered.


Revlimid Side Effects Report #5570547-3
REVLIMID problem was reported by a Health Professional from UNITED STATES on Dec 12, 2007. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . REVLIMID dosage: unknown. Patient recovered.

Revlimid Side Effects Report #5570574-6
Pharmacist from UNITED STATES reported REVLIMID problem on Dec 11, 2007. Female patient, 64 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . REVLIMID dosage: 25 MG, OD, ORAL. During the same period patient was treated with DEXAMETHASONE, ATENOLOL, ALLOPURINOL, LEVOTHYROXINE, POTASSIUM, LASIX. Patient recovered.

Revlimid Side Effects Report #5581099-6
REVLIMID problem was reported by a Health Professional from UNITED STATES on Dec 26, 2007. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . REVLIMID dosage: unknown. Patient recovered.

Etoposide Side Effects Report #5521592-5
Health Professional from DENMARK reported ETOPOSIDE problem on Nov 05, 2007. Male patient, 23 years of age, was diagnosed with medulloblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . ETOPOSIDE dosage: 50 MG/M2 Q D X 5 D, Q 3 WEEKS. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Sutent Side Effects Report #5524210-5
SUTENT problem was reported by a Physician from UNITED STATES on Nov 09, 2007. Female patient, weighting 169.3 lb, was diagnosed with clear cell carcinoma of the kidney, nausea, insomnia, urinary tract infection, pain and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . SUTENT dosage: unknown. During the same period patient was treated with COMPAZINE, ATIVAN, AMBIEN, LEVAQUIN, MAGIC MOUTHWASH, VIVELLE, PROZAC, ALLEGRA. Patient died on 09/10/2007.


Cytarabine Side Effects Report #5532122-6
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Nov 30, 2007. Male patient, weighting 249.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . CYTARABINE dosage: 484 MG. During the same period patient was treated with DAUNORUBICIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5475005-2
ERBITUX problem was reported by a Physician from GERMANY on Sept 24, 2007. Male patient, 53 years of age, was diagnosed with lip and/or oral cavity cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . ERBITUX dosage: unknown. During the same period patient was treated with DICLOFENAC, NOVAMINSULFON, METOPROLOL, PANTOPRAZOLE, CANDESARTAN CILEXETIL. Patient was hospitalized. Patient died on 08/20/2007.

Ganciclovir Side Effects Report #5480475-X
Health Professional from UNITED STATES reported GANCICLOVIR problem on Sept 27, 2007. Female patient was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . GANCICLOVIR dosage: unknown. During the same period patient was treated with ARGININE BUTYRATE. Patient died.

Ganciclovir Side Effects Report #5480479-7
GANCICLOVIR problem was reported by a Health Professional from UNITED STATES on Sept 27, 2007. Female patient was diagnosed with t-cell lymphoma and was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . GANCICLOVIR dosage: unknown. During the same period patient was treated with ARGININE BUTYRATE. Patient died.

Ganciclovir Side Effects Report #5480484-0
Physician from UNITED STATES reported GANCICLOVIR problem on Sept 27, 2007. Female patient was diagnosed with t-cell lymphoma and was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . GANCICLOVIR dosage: unknown. During the same period patient was treated with ARGININE BUTYRATE. Patient died.


Ganciclovir Side Effects Report #5480536-5
GANCICLOVIR problem was reported by a Health Professional from UNITED STATES on Sept 27, 2007. Female patient was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . GANCICLOVIR dosage: unknown. During the same period patient was treated with ARGININE BUTYRATE. Patient died.

Ganciclovir Side Effects Report #5480591-2
Health Professional from UNITED STATES reported GANCICLOVIR problem on Sept 27, 2007. Female patient was diagnosed with t-cell lymphoma and was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . GANCICLOVIR dosage: unknown. During the same period patient was treated with ARGININE BUTYRATE. Patient died.

Ganciclovir Side Effects Report #5480611-5
GANCICLOVIR problem was reported by a Physician from UNITED STATES on Sept 27, 2007. Female patient was diagnosed with t-cell lymphoma and was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . GANCICLOVIR dosage: unknown. During the same period patient was treated with ARGININE BUTYRATE. Patient died.

Erbitux Side Effects Report #5481382-9
Physician from GERMANY reported ERBITUX problem on Oct 02, 2007. Male patient, 52 years of age, was diagnosed with lip and/or oral cavity cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . ERBITUX dosage: unknown. During the same period patient was treated with VOLTAREN, NOVAMINSULFON, METOPROLOL TARTRATE, PANTOPRAZOLE, ATACAND HCT, BISACODYL. Patient was hospitalized. Patient died on 08/21/2007.

Gemcitabine Side Effects Report #5503144-6
GEMCITABINE problem was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Oct 17, 2007. Female patient, 75 years of age, was diagnosed with transitional cell carcinoma and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . GEMCITABINE dosage: 1200 MG/M2, AS A 30 MINUTES INFUSION. Patient was hospitalized. Patient died.

Sutent Side Effects Report #5429887-0
Consumer or non-health professional from UNITED STATES reported SUTENT problem on Aug 15, 2007. Male patient, 56 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . SUTENT dosage: unknown. Patient died.

Docetaxel Side Effects Report #5764887-2
DOCETAXEL problem was reported by a Consumer or non-health professional from JAPAN on June 04, 2008. Male patient, 57 years of age, was treated with DOCETAXEL. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . DOCETAXEL dosage: unknown. During the same period patient was treated with NEDAPLATIN. Patient recovered.

Dexamethasone Side Effects Report #5788857-3
Health Professional from GERMANY reported DEXAMETHASONE problem on June 17, 2008. Male patient, child 8 years of age, weighting 59.52 lb, was diagnosed with prophylaxis of nausea and vomiting, anaesthesia, pain prophylaxis and was treated with DEXAMETHASONE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . DEXAMETHASONE dosage: 4 MG IMMEDIATELY AFTER INDUCTION OF ANESTHESIA. During the same period patient was treated with PROPOFOL, ALFENTANIL, DESFLURANE, REMIFENTANIL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Fludara Side Effects Report #5732712-1
FLUDARA problem was reported by a Physician from LEBANON on Apr 28, 2008. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . FLUDARA dosage: UNIT DOSE: 25 MG/M2. Patient died on 01/22/2007.

Erbitux Side Effects Report #5745080-6
Health Professional from GERMANY reported ERBITUX problem on May 16, 2008. Male patient, 64 years of age, was diagnosed with colon cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . ERBITUX dosage: unknown. Patient died.

Carboplatin Side Effects Report #5752334-6
CARBOPLATIN problem was reported by a Health Professional from KOREA, REPUBLIC OF on May 27, 2008. Male patient, 74 years of age, was diagnosed with pleural mesothelioma malignant and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . CARBOPLATIN dosage: unknown. During the same period patient was treated with PEMETREXED DI. Patient died.

Erlotinib Side Effects Report #5712020-5
Physician from JAPAN reported ERLOTINIB problem on Apr 02, 2008. Female patient, 56 years of age, was diagnosed with lung adenocarcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . ERLOTINIB dosage: (150 MG,QD),ORAL ; (100 MG, QD), ORAL. During the same period patient was treated with ALDACTONE, CYTOTEC, VOLTAREN, HOCHU, LASIX, MEXITIL, METHYCOBAL. Patient recovered.

Capecitabine Side Effects Report #5718213-5
CAPECITABINE problem was reported by a Health Professional from KOREA, REPUBLIC OF on Apr 14, 2008. Male patient, 38 years of age, was diagnosed with gastric cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . CAPECITABINE dosage: unknown. During the same period patient was treated with CISPLATIN. Patient recovered.

Vepesid Side Effects Report #5369374-1
Consumer or non-health professional from UNITED STATES reported VEPESID problem on June 21, 2007. Male patient, 21 years of age, was diagnosed with burkitt's lymphoma and was treated with VEPESID. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . VEPESID dosage: unknown. During the same period patient was treated with ENDOXAN, METHOTREXATE, IFOMIDE, VINCRISTINE SULPHATE, DOXORUBICIN, CYTARABINE. Patient recovered.

Hydroxyurea Side Effects Report #5315484-4
HYDROXYUREA problem was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on May 01, 2007. Male patient, 74 years of age, was diagnosed with chronic myeloid leukaemia, splenomegaly and was treated with HYDROXYUREA. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . HYDROXYUREA dosage: unknown. During the same period patient was treated with ALLOPURINOL. Patient was hospitalized. Patient recovered.

Hydroxycarbamide Side Effects Report #5315485-6
Health Professional from LEBANON reported HYDROXYCARBAMIDE problem on May 01, 2007. Male patient, 61 years of age, was diagnosed with chronic myelomonocytic leukaemia and was treated with HYDROXYCARBAMIDE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . HYDROXYCARBAMIDE dosage: unknown. During the same period patient was treated with ALLOPURINOL. Patient was hospitalized. Patient recovered.

Vepesid Side Effects Report #5331111-4
VEPESID problem was reported by a Health Professional from JAPAN on May 15, 2007. Male patient, 21 years of age, was diagnosed with burkitt's lymphoma and was treated with VEPESID. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . VEPESID dosage: unknown. During the same period patient was treated with ENDOXAN, METHOTREXATE, IFOMIDE, VINCRISTINE SULPHATE, DOXORUBICIN. Patient recovered.

Dexamethasone Side Effects Report #5293997-1
Physician from UNITED STATES reported DEXAMETHASONE problem on Mar 29, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma and was treated with DEXAMETHASONE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . DEXAMETHASONE dosage: 40 MG QD, ON DAYS 1-4,9 2,17-20, UNK. During the same period patient was treated with THALIDOMIDE, DARBEPOETIN ALFA, ZOLEDRONIC ACID, WARFARIN. Patient was hospitalized. Patient recovered.

Avastin Side Effects Report #5300817-5
AVASTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 2007. Male patient, 72 years of age, was diagnosed with colorectal cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . AVASTIN dosage: 5 MG/KG, UNK. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient died on 01/08/2007.

Velcade Side Effects Report #5615692-9
Physician from JAPAN reported VELCADE problem on Jan 23, 2008. Female patient, 73 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, tumour lysis syndrome, . VELCADE dosage: unknown. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5583865-X
REVLIMID problem was reported by a Health Professional from UNITED STATES on Dec 21, 2007. Male patient, 79 years of age, weighting 166.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood creatine increased, tumour lysis syndrome, . REVLIMID dosage: 2.5 MG, DAILY, ORAL. During the same period patient was treated with ALLOPURINOL, ANTIBIOTIC. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5584689-X
Physician from JAPAN reported VELCADE problem on Dec 19, 2007. Male patient, 58 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: dialysis, tumour lysis syndrome, . VELCADE dosage: 2.00 MG, INTRAVENOUS. Patient died on 12/12/2007.

Irinotecan Side Effects Report #5584703-1
IRINOTECAN problem was reported by a Consumer or non-health professional from GERMANY on Jan 02, 2008. Male patient, 62 years of age, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, tumour lysis syndrome, . IRINOTECAN dosage: unknown. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, FOLINIC ACID, BEVACIZUMAB. Patient died.

Avastin Side Effects Report #5592391-3
Physician from GERMANY reported AVASTIN problem on Jan 07, 2008. Male patient, 62 years of age, was diagnosed with colorectal cancer metastatic, colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: renal failure acute, tumour lysis syndrome, . AVASTIN dosage: 5 MG/KG, UNK. During the same period patient was treated with IRINOTECAN, FOLINIC ACID, FLUOROURACIL. Patient died.

Campath Side Effects Report #5603709-7
CAMPATH problem was reported by a Physician from UNITED STATES on Jan 15, 2008. Male patient, 20 years of age, weighting 233.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, tumour lysis syndrome, white blood cell count decreased, . CAMPATH dosage: unknown. During the same period patient was treated with METHOTREXATE, VINCRISTINE, ELSPAR, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Campath Side Effects Report #5607656-6
Physician from UNITED STATES reported CAMPATH problem on Jan 18, 2008. Male patient, 20 years of age, weighting 233.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, tumour lysis syndrome, white blood cell count decreased, . CAMPATH dosage: unknown. During the same period patient was treated with METHOTREXATE, VINCRISTINE, ELSPAR, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Taxol Side Effects Report #5564374-0
TAXOL problem was reported by a Health Professional from JAPAN on Dec 12, 2007. Female patient, 60 years of age, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, tumour lysis syndrome, . TAXOL dosage: unknown. Patient died.

Rituximab Side Effects Report #5509091-8
Consumer or non-health professional from FRANCE reported RITUXIMAB problem on Oct 29, 2007. Male patient, weighting 160.9 lb, was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, tumour lysis syndrome, . RITUXIMAB dosage: 690 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Decadron Side Effects Report #5512950-3
DECADRON problem was reported by a Physician from JAPAN on Nov 05, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, tumour lysis syndrome, . DECADRON dosage: unknown. During the same period patient was treated with VELCADE. Patient recovered.

Decadron Side Effects Report #5521014-4
Physician from JAPAN reported DECADRON problem on Nov 07, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, tumour lysis syndrome, . DECADRON dosage: unknown. During the same period patient was treated with VELCADE. Patient recovered.

Allopurinol Side Effects Report #5528378-6
ALLOPURINOL problem was reported by a Health Professional from UNITED KINGDOM on Nov 07, 2007. Female patient, 47 years of age, was diagnosed with chronic myeloid leukaemia and was treated with ALLOPURINOL. After drug was administered, patient experienced the following problems/side effects: renal failure, tumour lysis syndrome, . ALLOPURINOL dosage: unknown. During the same period patient was treated with CYTARABINE, FLUDARABINE PHOSPHATE, IDARUBICIN, RASBURICASE. Patient was hospitalized. Patient recovered.

Allopurinol Side Effects Report #5530259-9
Health Professional from UNITED KINGDOM reported ALLOPURINOL problem on Nov 12, 2007. Male patient, 43 years of age, was treated with ALLOPURINOL. After drug was administered, patient experienced the following problems/side effects: renal failure acute, tumour lysis syndrome, . ALLOPURINOL dosage: unknown. Patient was hospitalized. Patient recovered.